"Systems And Methods For Diagnosis And/Or Treating Demyelinating Neuropathy" in Patent Application Approval Process (USPTO 20240277285).

A patent application by inventor Nizar Souayah describes systems and methods for diagnosing and treating demyelinating neuropathy. The application proposes using electrodes to measure muscle integrity and obtaining a biological sample, such as urine, to determine biomarker activity. By inputting these measures into a regression model, patients with demyelinating neuropathy can be identified and treated with appropriate agents. The patent application provides specific examples for treating distal symmetric polyneuropathy, peripheral neuropathy, and chronic inflammatory demyelinating polyneuropathy. [Extracted from the article]